On Monday, Neurogene Inc (NASDAQ: NGNE) was 43.26% up from the session before settling in for the closing price of $46.07. A 52-week range for NGNE has been $12.49 – $55.21.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -20.00%. When this article was written, the company’s average yearly earnings per share was at -250.46%. With a float of $10.28 million, this company’s outstanding shares have now reached $12.82 million.
Considering the fact that the conglomerate employs 91 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is -323.57%, operating margin of -8756.32%, and the pretax margin is -5993.62%.
Neurogene Inc (NGNE) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Neurogene Inc stocks. The insider ownership of Neurogene Inc is 20.86%, while institutional ownership is 92.50%.
Neurogene Inc (NGNE) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -250.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.10% during the next five years compared to -16.09% drop over the previous five years of trading.
Neurogene Inc (NASDAQ: NGNE) Trading Performance Indicators
You can see what Neurogene Inc (NGNE) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 12.17. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 965.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.71, a number that is poised to hit -1.22 in the next quarter and is forecasted to reach -4.51 in one year’s time.
Technical Analysis of Neurogene Inc (NGNE)
Compared to the last year’s volume of 0.12 million, its volume of 0.26 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 42.30%. Additionally, its Average True Range was 4.82.
During the past 100 days, Neurogene Inc’s (NGNE) raw stochastic average was set at 82.71%, which indicates a significant increase from 75.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 157.89% in the past 14 days, which was higher than the 100.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.66, while its 200-day Moving Average is $38.04. Nevertheless, the first resistance level for the watch stands at $74.73 in the near term. At $83.45, the stock is likely to face the second major resistance level. The third major resistance level sits at $93.32. If the price goes on to break the first support level at $56.14, it is likely to go to the next support level at $46.27. Now, if the price goes above the second support level, the third support stands at $37.55.
Neurogene Inc (NASDAQ: NGNE) Key Stats
There are 12,994K outstanding shares of the company, which has a market capitalization of 897.73 million. As of now, sales total 0 K while income totals -36,320 K. Its latest quarter income was 930 K while its last quarter net income were -18,490 K.
